TuftsCSDD-Logo-Color.jpg
Drug Developers Are Aggressively Changing the Way They Do R&D, According to Tufts Center for the Study of Drug Development
05 janv. 2011 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - January 5, 2011) - With dozens of prescription drugs due to lose their patent protection in the next few years, and few likely blockbusters in company pipelines to replace...
TuftsCSDD-Logo-Color.jpg
Personalized Medicines Are Shaping the Way R&D Is Done, According to Tufts Center for the Study of Drug Development
16 nov. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - November 16, 2010) - Personalized medicine development, occupying a growing role in the clinical pipelines of drug developers, is leading companies to change their R&D...
TuftsCSDD-Logo-Color.jpg
Pharma and Biotech Firms Are Rethinking Their Approach to Outsourcing, According to Tufts Center for the Study of Drug Development
26 oct. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - October 26, 2010) -  The current business climate is challenging pharmaceutical and biotech companies to rethink their approach to outsourcing and how best to build...
TuftsCSDD-Logo-Color.jpg
Approval Success Rates Higher for Smaller Firms Among Top 50 Pharmaceutical Companies, According to Tufts Center for the Study of Drug Development
09 sept. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - September 9, 2010) - The top 10 pharmaceutical companies out of the world's top 50 have lower estimated overall clinical approval success rates than do smaller firms in that...
TuftsCSDD-Logo-Color.jpg
Portfolio Management Is Key to Improved Drug Development Productivity, According to Tufts Center for the Study of Drug Development
11 août 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - August 11, 2010) -  Drug developers need to change the way they allocate resources for new product development, lifecycle management, and business development and...
TuftsCSDD-Logo-Color.jpg
Comparative Effectiveness Research Could Alter Pharmaceutical Care in the United States, According to Tufts Center for the Study of Drug Development
08 juil. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - July 8, 2010) -  Comparative effectiveness research, which assesses the relative strengths and weaknesses of various medical interventions, could help close the gap...
TuftsCSDD-Logo-Color.jpg
Rising Clinical Trial Complexity Continues to Vex Drug Developers, According to Tufts Center for the Study of Drug Development
05 mai 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - May 5, 2010) - Growing clinical trial complexity continues to challenge the ability of pharmaceutical and biotechnology companies to contain the ever-rising cost of...
TuftsCSDD-Logo-Color.jpg
New Approaches to R&D May Prove Best Path for Drug Developers, According to Tufts Center for the Study of Drug Development
06 avr. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - April 6, 2010) -  Innovative approaches to drug development, including alliances and partnerships, may prove the best way to increase the rate at which the...
TuftsCSDD-Logo-Color.jpg
Regulatory Affairs Workload at Drug Development Firms Has Increased Dramatically, According to Tufts Center for the Study of Drug Development
11 mars 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - March 11, 2010) -  A growing volume of global drug development and commercialization activity during the past decade has dramatically increased the workload for...
TuftsCSDD-Logo-Color.jpg
Tufts Center for the Study of Drug Development Launches New Website to Support Research on Critical Drug Development Issues
28 janv. 2010 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - January 28, 2010) - The Tufts Center for the Study of Drug Development, the world's leading, independent authority on the nature and pace of pharmaceutical and biotech drug...